▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Thomson Reuters Q1 22 Earnings Conference Call At 9:00 AM ET

By RTTNews Staff Writer ✉ | Published: 5/3/2022 8:00 AM ET

Thomson Reuters Corporation (TRI) will host a conference call at 9:00 AM ET on May 3, 2022, to discuss Q1 22 earnings results.

To access the live webcast, log on to https://ir.thomsonreuters.com/news-and-events/investor-events

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In February 2022 non small cell lung cancer chemotherapy

Biotech Stocks Facing FDA Decision In February 2022

Latest Updates on COVID-19

193K New Covid Cases, 710 Deaths In U.S.

18K New Covid Cases, 144 Deaths In US

Pfizer Signs $3.2 Bln COVID Vaccine Deal With US Government

125K New Covid Cases, 549 Deaths In U.S.

FDA Experts Recommend Updated Booster Shots To Fight Contagious Omicron Variant In Fall

Read More

COVID-19: Drugs in Development

RELATED NEWS

Thomson Reuters Announces $2.0 Bln Share Repurchase Program

Thomson Reuters To Present At The TD Securities Telecom & Media Conference; Webcast At 1:00 PM ET

Thomson Reuters Q1 22 Earnings Conference Call At 9:00 AM ET

Thomson Reuters Lifts FY22 Revenue Growth View; Backs FY23 Forecast - Update

Thomson Reuters Corporation Q1 Profit Decreases, misses estimates

Follow RTT

Editor's Pick
Most Read
Most Emailed

FCC Authorizes SpaceX To Use Starlink Internet Service On Vehicles In Motion

Loud Muscle Science Recalls Launch Sequence Products

US To Import 17 Mln Bottles Of Infant Formula From New Zealand, Ireland

Children's Sleepwear Sold At Amazon Recalled

Pfizer Signs $3.2 Bln COVID Vaccine Deal With US Government

Samsung Starts Mass Production Of Most Advanced 3-nm Chips

Morphine Sulfate Extended-Release Tablets Recalled Due To Label-Mix Up

FTC Sues Walmart For Facilitating Money Transfer Fraud

Bed Bath & Beyond Q1 Results Miss Estimates

Tesla Cuts 200 Autopilot Jobs, Closes San Mateo Office

FDA Experts Recommend Updated Booster Shots To Fight Contagious Omicron Variant In Fall

Creminelli Recalls Mini Parmesan Salami Stick Products

FCC Authorizes SpaceX To Use Starlink Internet Service On Vehicles In Motion

Walmart To Buy Memomi For Undisclosed Sum

Teva Pharmaceutical Appoints Eric Hughes As Chief Medical Officer

Missfresh Finds 'Questionable Transactions' In Internal Review

General Mills Gains On Upbeat Q4 Results, Increased Dividend

Cytokinetics Declines 8% Following $450 Mln Notes Offering

Blueprint Medicines Enters Financing Collaborations With Sixth Street And Royalty Pharma

Micron Technology Q3 Profit Increases, beats estimates

Ardelyx To Receive Up To $20 Mln Financing Deal With HealthCare Royalty Partners

Brickell Biotech Announces 1-to-45 Reverse Stock Split, Stock Tanks

Walgreens Boots Alliance, Inc. Q3 Profit Decreases, but beats estimates

Pfizer Signs $3.2 Bln COVID Vaccine Deal With US Government

Walgreens Boots Alliance, Inc. Q3 Profit Decreases, but beats estimates

Plusgrade Completes Acquisition Of Points.com

Spirax-Sarco Engineering Plc To Acquire Vulcanic Group From Qualium

US Supreme Court Turns Away Alaska Airlines Plea In Labor Law Case

Shoe Zone Sees FY22 Adj. Pretax Profit Not Less Than £8.5 Mln, Margin Growth; Stock Up

TUI Repays Silent Participation II; Reduces KfW Credit Lines

Virgin Money UK To Repurchase 75 Mln Pounds Of Shares

Stagecoach FY Adj. Pretax Profit Rises

Missfresh Finds 'Questionable Transactions' In Internal Review

Booz Allen Disagrees With U.S. DoJ's Characterization Of Proposed EverWatch Deal

Gerresheimer Signs New EUR 150 Mln Credit Facility

Barnes & Noble Education, Inc. Q4 Loss Decreases